Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Weitere Versionen anzeigen (1)

Bibliographische Detailangaben
Hauptverfasser:	Sandham, D, Chen, W, Hardman, C, Luo, J, Xue, L, Ogg, G, Erpenbeck, V
Format:	Conference item
Sprache:	English
Veröffentlicht:	Wiley 2019

Ähnliche Einträge

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
von: Chen, W, et al.
Veröffentlicht: (2018)

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
von: Xue, L, et al.
Veröffentlicht: (2018)

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
von: Hardman, C, et al.
Veröffentlicht: (2019)

Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
von: Xue, L, et al.
Veröffentlicht: (2019)

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
von: Hardman, CS, et al.
Veröffentlicht: (2021)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells
von: Xue, L, et al.
Veröffentlicht: (2013)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.
von: Xue, L, et al.
Veröffentlicht: (2014)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
von: Ogg, G, et al.
Veröffentlicht: (2015)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
von: Salimi, M, et al.
Veröffentlicht: (2015)

Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation
von: Esmaeil Mortaz, et al.
Veröffentlicht: (2018-01-01)

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
von: Luo, J, et al.
Veröffentlicht: (2019)

Group 2 Innate Lymphoid Cells (ILC2) Suppress Beneficial Type 1 Immune Responses During Pulmonary Cryptococcosis
von: Markus Kindermann, et al.
Veröffentlicht: (2020-02-01)

Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules
von: Noha Mousaad Elemam, et al.
Veröffentlicht: (2017-12-01)

Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and Skin-Resident ILC2
von: Minori Nakatani-Kusakabe, et al.
Veröffentlicht: (2021-09-01)

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells
von: Hardman, C, et al.
Veröffentlicht: (2017)

Cysteinyl leukotriene E4 activates human ILC2s and enhances the effect of prostaglandin D2 and epithelial cytokines
von: Salimi, M, et al.
Veröffentlicht: (2017)

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
von: Veit J. Erpenbeck, et al.
Veröffentlicht: (2016-12-01)

The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
von: Christian Domingo, et al.
Veröffentlicht: (2018-09-01)

Group 2 innate lymphoid cells and asthma
von: Hiroki Kabata, et al.
Veröffentlicht: (2015-07-01)

Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis
von: Rita G. Domingues, et al.
Veröffentlicht: (2020-02-01)

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
von: Gonem, S, et al.
Veröffentlicht: (2016)

Prostaglandin E2 Inhibits Group 2 Innate Lymphoid Cell Activation and Allergic Airway Inflammation Through E-Prostanoid 4-Cyclic Adenosine Monophosphate Signaling
von: Yu Zhou, et al.
Veröffentlicht: (2018-03-01)

Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa
von: Andreea Petrasca, et al.
Veröffentlicht: (2023-01-01)

Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.
von: Andreea Petrasca, et al.
Veröffentlicht: (2023-01-01)

Evaluation of Innate Lymphoid Cells (ILCs) Population in the Mouse Model of Colorectal Cancer
von: Seyed Mohammad Javadzadeh, et al.
Veröffentlicht: (2022-12-01)

ILC-You in the Thymus: A Fresh Look at Innate Lymphoid Cell Development
von: Samuel B. Shin, et al.
Veröffentlicht: (2021-05-01)

Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation
von: Jacqueline-Yvonne Cephus, et al.
Veröffentlicht: (2017-11-01)

Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma.
von: Christina Gress, et al.
Veröffentlicht: (2024-01-01)

Group 2 Innate Lymphoid Cells in Allergic Rhinitis
von: Wang S, et al.
Veröffentlicht: (2024-11-01)

Group 2 innate lymphoid cells and their surrounding environment
von: Maiko Naito, et al.
Veröffentlicht: (2023-03-01)

Group 2 innate lymphoid cells in human asthma
von: Arifumi Iwata, et al.
Veröffentlicht: (2023-04-01)

The Fate of Activated Group 2 Innate Lymphoid Cells
von: Laura Mathä, et al.
Veröffentlicht: (2021-04-01)

Increased circulating innate lymphoid cell (ILC)1 and decreased circulating ILC3 are involved in the pathogenesis of Henoch-Schonlein purpura
von: Lili Zhang, et al.
Veröffentlicht: (2022-04-01)

IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice
von: Yuka Hosotani, et al.
Veröffentlicht: (2023-04-01)

The Functional Role of Group 2 Innate Lymphoid Cells in Asthma
von: Takahiro Matsuyama, et al.
Veröffentlicht: (2023-05-01)

Tissue Resident and Migratory Group 2 Innate Lymphoid Cells
von: Laura Mathä, et al.
Veröffentlicht: (2022-04-01)

Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation
von: Sofia Helfrich, et al.
Veröffentlicht: (2019-06-01)

The Regulation of the IL-18 on Group 2 Innate Lymphoid Cells in Allergic Rhinitis
von: Chuling Li, et al.
Veröffentlicht: (2021-09-01)

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis
von: Salimi, M, et al.
Veröffentlicht: (2014)

The roles of type 2 cytotoxic T cells in inflammation, tissue remodeling, and prostaglandin (PG) D2 production are attenuated by PGD2 receptor 2 antagonism
von: Chen, W, et al.
Veröffentlicht: (2021)